<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21865426</PMID><DateCompleted><Year>2012</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-660X</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>10</Issue><PubDate><Year>2011</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of clinical microbiology</Title><ISOAbbreviation>J Clin Microbiol</ISOAbbreviation></Journal><ArticleTitle>External quality assessment for enterovirus 71 and coxsackievirus A16 detection by reverse transcription-PCR using armored RNA as a virus surrogate.</ArticleTitle><Pagination><StartPage>3591</StartPage><EndPage>3595</EndPage><MedlinePgn>3591-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JCM.00686-11</ELocationID><Abstract><AbstractText>Three armored RNAs (virus-like particles [VLPs]) containing target sequences from enterovirus 71 (EV71) and coxsackievirus A16 (CA16) and a pan-enterovirus (pan-EV) sequence were constructed and used in an external quality assessment (EQA) to determine the performance of laboratories in the detection of EV71 and CA16. The EQA panel, which consisted of 20 samples, including 14 positive samples with different concentrations of EV and either EV71 or CA16 armored RNAs, 2 samples with all 3 armored RNAs, and 4 negative-control samples (NaN(3)-preserved minimal essential medium [MEM] without VLPs), was distributed to 54 laboratories that perform molecular diagnosis of hand, foot, and mouth disease (HFMD) virus infections. A total of 41 data sets from 41 participants were returned; 5 (12.2%) were generated using conventional in-house reverse transcription-PCR (RT-PCR) assays, and 36 (87.8%) were generated using commercial real-time RT-PCR assays. Performance assessments of laboratories differed; 12 (29.3%) showed a need for improvement. Surprisingly, 4 laboratories were unable to detect EV71 RNA in any samples, even those containing the highest concentration of 10(7) IU/ml. Furthermore, the detection sensitivity for EV71 among all laboratories (82.1%) was substantially lower than that for EV (97.4%) or CA16 (95.1%). Overall, the results of the present study indicate that EQA should be performed periodically to help laboratories monitor their ability to detect HFMD viruses and to improve the comparability of results from different laboratories.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Liqiong</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Shipeng</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bo</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Yang</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wenli</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kuo</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jinming</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>08</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Microbiol</MedlineTA><NlmUniqueID>7505564</NlmUniqueID><ISSNLinking>0095-1137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025202" MajorTopicYN="N">Molecular Diagnostic Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012015" MajorTopicYN="Y">Reference Standards</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014773" MajorTopicYN="N">Virology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2012</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21865426</ArticleId><ArticleId IdType="pmc">PMC3187324</ArticleId><ArticleId IdType="doi">10.1128/JCM.00686-11</ArticleId><ArticleId IdType="pii">JCM.00686-11</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aarthi D., Ananda Rao K., Robinson R., Srinivasan V. A. 2004. Validation of binary ethyleneimine (BEI) used as an inactivant for foot and mouth disease tissue culture vaccine. Biologicals 32:153&#x2013;156</Citation><ArticleIdList><ArticleId IdType="pubmed">15536046</ArticleId></ArticleIdList></Reference><Reference><Citation>AbuBakar S., et al. 1999. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res. 61:1&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">10426204</ArticleId></ArticleIdList></Reference><Reference><Citation>Beld M., et al. 2004. Highly sensitive assay for detection of enterovirus in clinical specimens by reverse transcription-PCR with an armored RNA internal control. J. Clin. Microbiol. 42:3059&#x2013;3064</Citation><ArticleIdList><ArticleId IdType="pmc">PMC446274</ArticleId><ArticleId IdType="pubmed">15243060</ArticleId></ArticleIdList></Reference><Reference><Citation>Bressler A. M., Nolte F. S. 2004. Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirus. J. Clin. Microbiol. 42:987&#x2013;991</Citation><ArticleIdList><ArticleId IdType="pmc">PMC356893</ArticleId><ArticleId IdType="pubmed">15004042</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan K. P., et al. 2003. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg. Infect. Dis. 9:78&#x2013;85</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2873753</ArticleId><ArticleId IdType="pubmed">12533285</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L. Y., et al. 2004. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA 291:222&#x2013;227</Citation><ArticleIdList><ArticleId IdType="pubmed">14722149</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L. Y., et al. 1999. Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr. Infect. Dis. J. 18:1092&#x2013;1096</Citation><ArticleIdList><ArticleId IdType="pubmed">10608631</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T. C., et al. 2006. Combining multiplex reverse transcription-PCR and a diagnostic microarray to detect and differentiate enterovirus 71 and coxsackievirus A16. J. Clin. Microbiol. 44:2212&#x2013;2219</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1489440</ArticleId><ArticleId IdType="pubmed">16757623</ArticleId></ArticleIdList></Reference><Reference><Citation>de Pagter P. J., Schuurman R., de Vos N. M., Mackay W., van Loon A. M. 2010. Multicenter external quality assessment of molecular methods for detection of human herpesvirus 6. J. Clin. Microbiol. 48:2536&#x2013;2540</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2897485</ArticleId><ArticleId IdType="pubmed">20147642</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo C., et al. 2010. 2nd international external quality control assessment for the molecular diagnosis of dengue infections. PLoS Negl. Trop. Dis. 4:e833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2950135</ArticleId><ArticleId IdType="pubmed">20957194</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo D. G., et al. 2008. Identification of immunodominant VP1 linear epitope of enterovirus 71 (EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in Western blots. Clin. Microbiol. Infect. 14:286&#x2013;288</Citation><ArticleIdList><ArticleId IdType="pubmed">18076666</ArticleId></ArticleIdList></Reference><Reference><Citation>Hietala S. K., Crossley B. M. 2006. Armored RNA as virus surrogate in a real-time reverse transcriptase PCR assay proficiency panel. J. Clin. Microbiol. 44:67&#x2013;70</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1351936</ArticleId><ArticleId IdType="pubmed">16390950</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q. Y., Cheng Y. J., Guo Q. W., Li Q. G. 2006. Preparation of a chimeric armored RNA as a versatile calibrator for multiple virus assays. Clin. Chem. 52:1446&#x2013;1448</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7542541</ArticleId><ArticleId IdType="pubmed">16798980</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T., et al. 2011. Development and evaluation of a reverse transcription-loop-mediated isothermal amplification assay for rapid detection of enterovirus 71. J. Clin. Microbiol. 49:870&#x2013;874</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3067723</ArticleId><ArticleId IdType="pubmed">21177907</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler H. H., et al. 1997. Rapid diagnosis of enterovirus infection by a new one-step reverse transcription-PCR assay. J. Clin. Microbiol. 35:976&#x2013;977</Citation><ArticleIdList><ArticleId IdType="pmc">PMC229714</ArticleId><ArticleId IdType="pubmed">9157166</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., et al. 2005. Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J. Clin. Microbiol. 43:3835&#x2013;3839</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1233905</ArticleId><ArticleId IdType="pubmed">16081920</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipson S. M., Walderman R., Costello P., Szabo K. 1988. Sensitivity of rhabdomyosarcoma and guinea pig embryo cell cultures to field isolates of difficult-to-cultivate group A coxsackieviruses. J. Clin. Microbiol. 26:1298&#x2013;1303</Citation><ArticleIdList><ArticleId IdType="pmc">PMC266596</ArticleId><ArticleId IdType="pubmed">2842370</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasloske B. L., Walkerpeach C. R., Obermoeller R. D., Winkler M., DuBois D. B. 1998. Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards. J. Clin. Microbiol. 36:3590&#x2013;3594</Citation><ArticleIdList><ArticleId IdType="pmc">PMC105245</ArticleId><ArticleId IdType="pubmed">9817878</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisani G., et al. 2008. External quality assessment for the detection of HCV RNA, HIV RNA and HBV DNA in plasma by nucleic acid amplification technology: a novel approach. Vox Sang. 95:8&#x2013;12</Citation><ArticleIdList><ArticleId IdType="pubmed">18380770</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu J. 2008. Enterovirus 71 infection: a new threat to global public health? Lancet Neurol. 7:868&#x2013;869</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128195</ArticleId><ArticleId IdType="pubmed">18848307</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu W. S., et al. 2010. Clinical and etiological characteristics of enterovirus 71-related diseases during a recent 2-year period in Korea. J. Clin. Microbiol. 48:2490&#x2013;2494</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2897491</ArticleId><ArticleId IdType="pubmed">20463159</ArticleId></ArticleIdList></Reference><Reference><Citation>Saldanha J., Lelie N., Heath A., and the WHO Collaborative Study Group 1999. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. Vox Sang. 76:149&#x2013;158</Citation><ArticleIdList><ArticleId IdType="pubmed">10341329</ArticleId></ArticleIdList></Reference><Reference><Citation>Simes R. 1986. An improved Bonferroni procedure for multiple tests of significance. Biometrika 73:751&#x2013;754</Citation></Reference><Reference><Citation>Thao N. T., et al. 2010. Development of a multiplex polymerase chain reaction assay for simultaneous identification of human enterovirus 71 and coxsackievirus A16. J. Virol. Methods 170:134&#x2013;139</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995219</ArticleId><ArticleId IdType="pubmed">20863857</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J. R., et al. 2002. Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J. Clin. Microbiol. 40:10&#x2013;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC120096</ArticleId><ArticleId IdType="pubmed">11773085</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S. Y., Lin T. L., Chen H. Y., Lin T. S. 2004. Early and rapid detection of enterovirus 71 infection by an IgM-capture ELISA. J. Virol. Methods 119:37&#x2013;43</Citation><ArticleIdList><ArticleId IdType="pubmed">15109819</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y. X., et al. 2008. RNase-resistant virus-like particles containing long chimeric RNA sequences produced by two-plasmid coexpression system. J. Clin. Microbiol. 46:1734&#x2013;1740</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2395109</ArticleId><ArticleId IdType="pubmed">18305135</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F., et al. 2010. Performance of detecting IgM antibodies against enterovirus 71 for early diagnosis. PLoS One 5:e11388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2894942</ArticleId><ArticleId IdType="pubmed">20613983</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., et al. 2009. Enterovirus 71 outbreak in the People's Republic of China in 2008. J. Clin. Microbiol. 47:2351&#x2013;2352</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2708525</ArticleId><ArticleId IdType="pubmed">19439545</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan S. E., et al. 2009. Armored long RNA controls or standards for branched DNA assay for detection of human immunodeficiency virus type 1. J. Clin. Microbiol. 47:2571&#x2013;2576</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2725685</ArticleId><ArticleId IdType="pubmed">19494069</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Lu J., Lu J. 2010. Enterovirus 71 vaccine: close but still far. Int. J. Infect. Dis. 14:e739&#x2013;e743</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110504</ArticleId><ArticleId IdType="pubmed">20400350</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>